Brendan Swain
Co-founder and Chief Scientific Officer at Shift Bioscience, Inventor of the first accurate cell aging clock
Brendan Swain, PhD, is currently serving as the Chief Scientific Officer at Shift Bioscience, a position held since March 2021. Prior to this role, Brendan completed a Doctor of Philosophy in Pharmacology at the University of Cambridge from 2016 to 2020, following an undergraduate degree in Natural Sciences with a focus on Pharmacology at the same institution from 2013 to 2016. Brendan's academic journey began at Dame Alice Owen's School, where studies were completed from 2006 to 2013.
Visit website: https://www.shiftbioscience.com/#team-investors
See also
Details last updated 06-Nov-2024
Brendan Swain is also referenced in the following:
74th Annual Scientific Meeting of the BSRA (2025)
03-Sep-2025
A compelling lineup of speakers from all areas of the biology of ageing (Manchester, UK)
Accelerating Healthy Longevity: From Code to Clinic
25-Sep-2025
This event celebrates the full spectrum of longevity and how it’s shaping the future of wellness, population health and our cities (London, UK)
Longevity Startup Panel: Will you live forever?
14-Nov-2024
Longevity panel with Shakiba Kaveh, Peter Hamley and Brendan Swain organised by OSAL (FREE, London, UK)
